Jane A. Buxton

10.2k total citations
339 papers, 7.3k citations indexed

About

Jane A. Buxton is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Jane A. Buxton has authored 339 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Epidemiology, 163 papers in Public Health, Environmental and Occupational Health and 64 papers in General Health Professions. Recurrent topics in Jane A. Buxton's work include Opioid Use Disorder Treatment (148 papers), HIV, Drug Use, Sexual Risk (125 papers) and Substance Abuse Treatment and Outcomes (74 papers). Jane A. Buxton is often cited by papers focused on Opioid Use Disorder Treatment (148 papers), HIV, Drug Use, Sexual Risk (125 papers) and Substance Abuse Treatment and Outcomes (74 papers). Jane A. Buxton collaborates with scholars based in Canada, United States and United Kingdom. Jane A. Buxton's co-authors include Thomas Kerr, Evan Wood, Ashraf Amlani, M‐J Milloy, Julio Montaner, Brandon D. L. Marshall, Margot Kuo, Alissa Greer, Kristi Papamihali and Lianping Ti and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Jane A. Buxton

329 papers receiving 7.1k citations

Peers

Countries citing papers authored by Jane A. Buxton

Since Specialization

Citations

This map shows the geographic impact of Jane A. Buxton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane A. Buxton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane A. Buxton more than expected).

Fields of papers citing papers by Jane A. Buxton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane A. Buxton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane A. Buxton. The network helps show where Jane A. Buxton may publish in the future.

Co-authorship network of co-authors of Jane A. Buxton

This figure shows the co-authorship network connecting the top 25 collaborators of Jane A. Buxton. A scholar is included among the top collaborators of Jane A. Buxton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane A. Buxton. Jane A. Buxton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring models of safer supply provision: A qualitative study on the preferences of people who access the unregulated drug market 2025 ·International Journal of Drug Policy ·(unknown), (unknown), (unknown), (unknown), Nancy Henderson, Karen Urbanoski, (unknown), (unknown), (unknown), Jane A. Buxton, Bernie Pauly	1
2	Prevalence and correlates of fentanyl test strip use among people who use drugs in Rhode Island 2024 ·Drug and Alcohol Dependence ·(unknown), Carolyn J. Park, (unknown), Ju Nyeong Park, Jane A. Buxton, Scott E. Hadland, Alexandria Macmadu, Brandon D. L. Marshall	3
3	Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized Trials 2024 ·International Journal of Mental Health and Addiction ·Malahat Khalili, (unknown), Paxton Bach, Alexis Crabtree, (unknown), Erfan Sadeghi, (unknown), (unknown), (unknown), (unknown), Ahmad Sofi‐Mahmudi, Naser Nasiri, (unknown), (unknown), (unknown), Jessica Moe, Mark Lysyshyn, Dan Werb, Jane A. Buxton, Mohammad Karamouzian	1
4	“Just clearly the right thing to do”: perspectives of correctional services leaders on moving governance of health-care in custody 2024 ·PubMed ·Katherine McLeod, Amanda Butler, Ruth Elwood Martin, Jane A. Buxton	1
5	Estimating the total utilization of take home naloxone during an unregulated drug toxicity crisis: A Bayesian modeling approach 2024 ·International Journal of Drug Policy ·Michael A. Irvine, (unknown), (unknown), Lisa Liu, (unknown), Brooke Kinniburgh, Daniel Coombs, Jane A. Buxton	1
6	People who use drugs’ prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study 2024 ·International Journal of Drug Policy ·(unknown), (unknown), Jane A. Buxton, (unknown), (unknown), (unknown), Alissa Greer	8
7	‘This is PEEP’ participatory qualitative study: learning from a provincial consultation and advisory group of people with lived and living experience of substance use in British Columbia, Canada 2024 ·BMJ Open ·(unknown), Kurt Lock, (unknown), Charlene Burmeister, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jane A. Buxton	2
8	Rising rates of infective endocarditis in North America: An urgent need for attention to the rapidly changing unregulated drug supply 2023 ·International Journal of Drug Policy ·Heather Palis, Joshua A. Barocas, Jessica Moe, (unknown), (unknown), Amanda Slaunwhite, Jane A. Buxton	3
9	Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia 2023 ·Substance Abuse Treatment Prevention and Policy ·(unknown), (unknown), (unknown), Lisa Liu, Brittany Graham, Kurt Lock, Jane A. Buxton	18
10	Staying Together No Matter What: Becoming Young Parents on the Streets of Vancouver 2023 ·Culture Medicine and Psychiatry ·Danya Fast, (unknown), (unknown), Andrea Krüsi, Jane A. Buxton, Sarah West, (unknown), Daniel Manson	5
11	Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada 2023 ·SHILAP Revista de lepidopterología ·(unknown), Lynda G. Balneaves, Jane A. Buxton, Thomas Kerr	1
12	What impact did the COVID-19 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply? An interrupted time-series analysis 2023 ·SHILAP Revista de lepidopterología ·Samuel Tobias, (unknown), (unknown), Mark Lysyshyn, Jane A. Buxton, Kenneth W. Tupper, Evan Wood, Lianping Ti	8
13	Preferred stimulant safer supply and associations with methamphetamine preference among people who use stimulants in British Columbia: Findings from a 2021 cross-sectional survey 2023 ·International Journal of Drug Policy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alexis Crabtree, (unknown), Lisa Liu, Jane A. Buxton	5
14	Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada 2022 ·International Journal of Drug Policy ·Sukhpreet Klaire, (unknown), (unknown), (unknown), Ellen Korol, (unknown), (unknown), (unknown), Jane A. Buxton, Mark Lysyshyn	18
15	Acceptability of Technological Solutions for Overdose Monitoring: Perspectives of People who use Drugs 2019 ·Substance Abuse ·Vivian W. L. Tsang, Kristi Papamihali, Alexis Crabtree, Jane A. Buxton	42
16	Building New Approaches to Risk Reduction With Social Networks and People Who Smoke Illegal Drugs From Participatory Community-Based Research 2018 ·International Journal of Qualitative Methods ·Ehsan Jozaghi, Jane A. Buxton, (unknown), (unknown), (unknown), Martin Bouchard	5
17	Association between Chronic Rhinosinusitis and Health-Related Quality of Life in Adults with Cystic Fibrosis 2015 ·Annals of the American Thoracic Society ·Al‐Rahim Habib, Jane A. Buxton, Joel Singer, Pearce Wilcox, Amin R. Javer, Bradley S. Quon	23
18	How do we capture 15 years of complex and meaningful data about young people's lives? 2011 ·Kōtuitui New Zealand Journal of Social Sciences Online ·(unknown), Jane A. Buxton, (unknown), (unknown), (unknown), (unknown)	2
19	Vaccination of health care workers for influenza: promote safety culture, not coercion. 2010 ·PubMed ·Annalee Yassi, Karen Lockhart, Jane A. Buxton, (unknown)	16
20	Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge. 2002 ·PubMed ·Joan L. Bottorff, Pamela A. Ratner, Lynda G. Balneaves, Chris G. Richardson, Mary McCullum, Thomas F. Hack, Karen Chalmers, Jane A. Buxton	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact